4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-09-000611
$MDGLCIK 0001157601operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:30 PM ET
Size
5.6 KB
Accession
0001179110-09-000611
Insider Transaction Report
Form 4
Chadwick Jeremy G
Sr. VP, Pgm Mgmt and Clin Ops
Transactions
- Sale
Common Stock
2009-01-05$6.20/sh−4,573$28,375→ 15,853 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2008, and were made to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock granted on December 21, 2004.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.18 to $6.295 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:30 PM ET
- Size
- 5.6 KB